Clinical research continues to create new opportunities for patients, health services and researchers across Aotearoa. Importantly clinical trials help provide access to some of theworld’s most cutting edge medical technologies including CRISPR, metabolic agonists and CAR-T cell therapies.
Our Aotearoa Clinical Trials (ACTT) Annual Report 2026 highlights a year of growth, collaboration and impact across New Zealand's largest public hospital-based clinical trials network.
This year saw the signing of the National Deed with Health New Zealand, allowing ACTT to work with any hospital in the country, alongside supporting more than 150 studies, including 52 actively enrolling trials, expansion of research capability in Whangārei, and reinvestment into research capability, workforce development and infrastructure.
Thank you to the participants, whānau, clinicians, researchers, sponsors and partners who make this work possible and help advance clinical research for communities across New Zealand.
Read the full Annual Report 2026 here
